Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMikawa, Takumi
dc.contributor.authorShibata, Eri
dc.contributor.authorShimada, Midori
dc.contributor.authorIto, Ken
dc.contributor.authorIto, Tomiko
dc.contributor.authorKanda, Hiroaki
dc.contributor.authorLleonart Pajarin, Matilde
dc.date.accessioned2021-12-28T07:53:09Z
dc.date.available2021-12-28T07:53:09Z
dc.date.issued2021-04-29
dc.identifier.citationMikawa T, Shibata E, Shimada M, Ito K, Ito T, Kanda H, et al. Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis. PLoS One. 2021 Apr 29;16(4):e0250856.
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11351/6744
dc.descriptionMouse models; Glycolysis; Diabetes mellitus
dc.description.abstractGlycolytic metabolism is closely involved in physiological homeostasis and pathophysiological states. Among glycolytic enzymes, phosphoglycerate mutase (PGAM) has been reported to exert certain physiological role in vitro, whereas its impact on glucose metabolism in vivo remains unclear. Here, we report the characterization of Pgam1 knockout mice. We observed that homozygous knockout mice of Pgam1 were embryonic lethal. Although we previously reported that both PGAM-1 and -2 affect global glycolytic profile of cancers in vitro, in vivo glucose parameters were less affected both in the heterozygous knockout of Pgam1 and in Pgam2 transgenic mice. Thus, the impact of PGAM on in vivo glucose metabolism is rather complex than expected before.
dc.language.isoeng
dc.publisherPublic Library Science
dc.relation.ispartofseriesPLoS One;16(4)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectGlucosa - Metabolisme
dc.subjectGenètica - Tècnica
dc.subjectRatolins transgènics
dc.subject.meshGlucose
dc.subject.mesh/metabolism
dc.subject.meshGene Knockout Techniques
dc.subject.meshMice
dc.titleCharacterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1371/journal.pone.0250856
dc.subject.decsglucosa
dc.subject.decs/metabolismo
dc.subject.decstécnicas de inactivación génica
dc.subject.decsratones
dc.relation.publishversionhttps://doi.org/10.1371/journal.pone.0250856
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Mikawa T, Shibata E, Ito K, Ito T] Geriatric Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. [Shimada M] Joint Faculty of Veterinary Science, Yamaguchi University, Yamaguchi, Japan. [Kanda H] Department of Pathology, Saitama Cancer Center, Saitama, Japan. [Lleonart ME] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33914812
dc.identifier.wos000664603100074
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record